Listed

ProPhase Labs, Inc.: Form 10-Q for the period ended Mar 31, 2012

Filed with the SEC on May 11, 2012 and accepted by EDGAR at May 11, 2012, 15:59 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2012-01-01 to 2012-03-31$6.0mus-gaap:SalesRevenueNet
Cost of revenue3 months2012-01-01 to 2012-03-31$1.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2012-01-01 to 2012-03-31$4.3mus-gaap:GrossProfit
Research and development3 months2012-01-01 to 2012-03-31$361.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2012-01-01 to 2012-03-31−$690.0kus-gaap:OperatingIncomeLoss
Income tax3 months2012-01-01 to 2012-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2012-01-01 to 2012-03-31−$688.0kus-gaap:NetIncomeLoss
Operating cash flow3 months2012-01-01 to 2012-03-31$775.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2012-01-01 to 2012-03-31$48.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-03-31$6.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-03-31$12.0mus-gaap:AssetsCurrent
Total assetsAt period end2012-03-31$17.9mus-gaap:Assets
Current liabilitiesAt period end2012-03-31$7.3mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2012-03-31$10.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-12-027886. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.